CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.
November 6th 2021
Lung cancer is a dangerous and often silent killer for the residents of northeast Georgia. For Dr. Arfoosh, lung cancer screening, quick referrals and prompt treatment for people with newly diagnosed lung cancer are at the forefront of his daily work.
November 5th 2021
After Kelsey Ahmed’s mother, Martha, was diagnosed with stage 4 non-small cell lung cancer, Kelsey and her family got to work raising funds and spreading awareness for the American Lung Association.
November 4th 2021
Patients who experience side effects due to immune checkpoint inhibitors are 80% more likely to go to the emergency room and have 30% higher monthly medical costs, compared to patients who did not have side effects.
In this episode of CURE’s “Cancer Horizons” podcast, three individuals, who were recognized as CURE Lung Cancer Heroes, spoke about what the honor means to them and bringing the lung cancer community together.
By creating a community of survivors, researchers, physicians and clinicians, The White Ribbon Project — under Heidi Nafman-Onda’s direction — has influenced real change.
November 3rd 2021
When cancer treatments stop working, it is not the end of the line. Most patients with advanced disease will be on continuous therapy, and that means trying different options along the way.
November 2nd 2021
The FDA approval is based on ‘substantial’ disease-free survival results and may ‘drastically’ improve lung cancer survival.
October 31st 2021
"Dr. Rosenzweig’s commitment to helping patients with lung cancer and mesothelioma is truly heroic," several colleagues write.
October 30th 2021
These are the powerful stories of real-life heroes in the lung cancer space who persevere with great compassion and teach us to embrace, not avoid, life’s setbacks and challenges.
October 29th 2021
"Dr. Hossein came to the United States by himself in his teens as a political refugee from the turmoil in Iran," writes a colleague who nominated him for the Lung Cancer Heroes® Award. "Completely on his own and through his hard work, scholarship, initiative and refusal to let things get him down, he went to college and then to medical school."
CURE®’s Lung Cancer Heroes® Award Program celebrates and thanks the heroes who make a difference in the lives of patients with lung cancer.
October 22nd 2021
From former New York Islanders hockey player Mike Bossy announcing that he has lung cancer to First Lady Jill Biden emphasizing the importance of breast cancer screenings, here’s what’s happening in the cancer landscape this week.
October 19th 2021
A company focused on treating underserved patients announced that the first patient with an NTRK fusion was dosed in a phase 2 trial of taletrectinib this summer.
October 15th 2021
The Food and Drug Administration approved adjuvant Tecentriq for patients with PD-L1—positive, stage 2 to 3A non-small cell lung cancer.
October 10th 2021
Aileron Therapeutics, Inc. announced the initiation of a clinical trial for ALRN-6924, a treatment for patients with non-small cell lung cancer.
October 7th 2021
Allison Collins reflects on the genetic testing she underwent after receiving a non-small cell lung cancer diagnosis and describes the treatment options presented to her at that time.
September 30th 2021
A woman explains how she received a lung cancer diagnosis while she was caring for her sick husband and what it was like to lose him in this episode of the “CURE® Talks Cancer” podcast.
Dr. Vamsidhar Velcheti provides an expert’s insight on the testing and staging that must be performed during a diagnosis of non-small cell lung cancer.
Considerations for the emotional impact of a lung cancer diagnosis and how patients can be supported during their treatment journey.
Allison Collins describes her diagnosis with KRAS-positive non-small cell lung cancer and the symptoms that led her to seek medical attention.
September 28th 2021
Here’s what patients should know about the recent FDA approval of Exkivity, the first oral therapy for patients with non-small cell lung cancer who have EFGR exon 20 insertion mutations.
September 27th 2021
Geographic disparities at the state-level are leading to increased rates of death from lung cancer, according to an expert.
September 24th 2021
The first patient was treated in the phase 2b KICKSTART trial testing the safety and efficacy of tomivosertib in combination with Keytruda.
September 23rd 2021
The prescription of systemic cancer therapies varies based on a patient’s age, comorbidities, cancer stage and other variables, according to recent research.
Ms. Addario, lung cancer survivor, encourages patients with non-small cell lung cancer to use all the resources and tools that are available to them.
Ms. Addario shares the promising hope for patients with lung cancer and describes the steps in the process of biomarker testing for patients with lung cancer.
Treating patients with lung cancer by identifying specific biomarkers to use the correct combination therapy and what it means for a biomarker to be actionable.
September 16th 2021
The eligible age of 65 years for Medicare may be discouraging patients from getting screenings and tests as they wait for more health coverage.
September 15th 2021
The FDA’s approval of Exkivity marks the first approved oral therapy for this subgroup of patients with non-small cell lung cancer.
Although immunotherapy has provided patients with small cell lung cancer with a “light at the end of the tunnel,” an expert from City of Hope argues more research is needed.
Cancer Care Improvements Have Come ‘Leaps and Bounds’ Over the Years
Oncologists Have Feelings Too: Navigating the Patient Physician Relationship
Debunking Myths of Clinical Trials for Cancer
Highlighting Geographic, Economic Disparities in Cancer Care